Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (111-120 of 715) with videos related to

Pageof 72
Sort By:
The American Journal of Cardiology|February 15, 1993
Strokes, statistics and sophistry in trials of thrombolysis for acute myocardial infarctionB E Sobel, D Collen
Arteriosclerosis, Thrombosis, and Vascular Biology|July 17, 2009
The tissue-type plasminogen activator storyD Collen, H R Lijnen
Thrombosis and Haemostasis|December 22, 1999
Matrix metalloproteinase system deficiencies and matrix degradationH R Lijnen, D Collen
Progress in Cardiovascular Diseases|January 1, 1997
Endothelium in hemostasis and thrombosisH R Lijnen, D Collen
Bailliere'S Clinical Haematology|June 1, 1995
Mechanisms of physiological fibrinolysisH R Lijnen, D Collen
Bailliere'S Clinical Haematology|June 1, 1995
New thrombolytic agents and strategiesD Collen, H R Lijnen
Thrombosis and Haemostasis|July 1, 1995
Molecular basis of fibrinolysis, as relevant for thrombolytic therapyD Collen, H R Lijnen
Annals of Epidemiology|July 1, 1992
On the role of coagulation and fibrinolysis in atherosclerosisI Juhan-Vague, D Collen
Arteriosclerosis (Dallas, Tex.)|November 1, 1984
New approaches to thrombolytic therapyD Collen, H R Lijnen
Advances in Experimental Medicine and Biology|January 1, 1984
Molecular mechanism of fibrinolysisH R Lijnen, D Collen
Pageof 72

Showing results (111-120 of 715) with videos related to

Sort By:
Pageof 72
The American Journal of Cardiology|February 15, 1993
Strokes, statistics and sophistry in trials of thrombolysis for acute myocardial infarctionB E Sobel, D Collen
Arteriosclerosis, Thrombosis, and Vascular Biology|July 17, 2009
The tissue-type plasminogen activator storyD Collen, H R Lijnen
Thrombosis and Haemostasis|December 22, 1999
Matrix metalloproteinase system deficiencies and matrix degradationH R Lijnen, D Collen
Progress in Cardiovascular Diseases|January 1, 1997
Endothelium in hemostasis and thrombosisH R Lijnen, D Collen
Bailliere'S Clinical Haematology|June 1, 1995
Mechanisms of physiological fibrinolysisH R Lijnen, D Collen
Bailliere'S Clinical Haematology|June 1, 1995
New thrombolytic agents and strategiesD Collen, H R Lijnen
Thrombosis and Haemostasis|July 1, 1995
Molecular basis of fibrinolysis, as relevant for thrombolytic therapyD Collen, H R Lijnen
Annals of Epidemiology|July 1, 1992
On the role of coagulation and fibrinolysis in atherosclerosisI Juhan-Vague, D Collen
Arteriosclerosis (Dallas, Tex.)|November 1, 1984
New approaches to thrombolytic therapyD Collen, H R Lijnen
Advances in Experimental Medicine and Biology|January 1, 1984
Molecular mechanism of fibrinolysisH R Lijnen, D Collen
Pageof 72